Feds' Biotech Enforcement Efforts Are Too Heavy-Handed

By Douglas Hallward-Driemeier, Laura Hoey and Alison Fethke · May 13, 2024, 5:26 PM EDT

A recent federal government settlement involving California-based biotech Ultragenyx is the latest example of how the U.S. Department of Justice's heavy-handed approach to enforcement of the federal Anti-Kickback Statute can punish...

To view the full article, register now.